PURE Bioscience (PURE) Reports FY09 Loss of $0.23
More News related to PURE
- One Year on, PureCircle Says, 'Stevia Becoming Mainstream'
- PURE Bioscience Assists Disaster Relief in Haiti
- PURE Bioscience's SDC Technology Featured on National H1N1 Education Tour
- Pure Bioscience (PURE) Post Q1 Loss of 5c, In-Line Y/Y
- PURE Bioscience (PURE) Hard Surface Disinfectant Effective Against H1NI
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
PURE Bioscience (NASDAQ: PURE) reports FY09 loss of $0.23, compared to a loss of $0.24 in the same quarter last year. Revenue for the year was $728,300, versus $1.49 million in '08.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
